COMMUNIQUÉS West-GlobeNewswire

Alkahest Initiates Phase 2 Clinical and Mechanistic Trial of Postoperative Recovery Following Primary Hip or Knee Arthroplasty
19/08/2019
SAN CARLOS, Calif., Aug. 19, 2019 (GLOBE NEWSWIRE) -- Alkahest, Inc., a clinical stage biotechnology company focused on developing transformative therapies to treat age-related diseases, today announced the dosing of [...]
Enlivex Therapeutics Announces Positive Outcome From Safety Committee’s Review Of Six Patients With Severe Sepsis Patients; Enrollment Of Last Study Cohort Approved
19/08/2019
Nes Ziona, Israel, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that the safety review committee of the Company’s ongoing Phase Ib [...]
Auxly Enters Into a 300 Acre Hemp Cultivation and Purchase Agreement for the 2019 Cultivation Season
19/08/2019
VANCOUVER, British Columbia, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") today announced that it has entered into a hemp cultivation and purchase agreement ( [...]
VitalHub and Strata Health Announce Strategic Collaboration To Enhance Health and Social Service Provider System Efficiencies Globally
19/08/2019
TORONTO, Aug. 19, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSXV: VHI) is pleased to announce that it has formalized a partnership with Strata Health, the global leader in intelligent patient transition technology. The [...]
The Joint Corp. Acquired Additional Clinic in the San Diego Market
19/08/2019
- Corporate Owned and Managed Portfolio Increases to 58 - SCOTTSDALE, Ariz., Aug. 19, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, [...]
Fulcrum Therapeutics Announces Initiation of ReDUX4, a Phase 2b Clinical Trial of Losmapimod for FSHD
19/08/2019
CAMBRIDGE, Mass., Aug. 19, 2019 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases [...]
Animal Health Veteran Johnny D. Powers Joins Zomedica Board of Directors
19/08/2019
ANN ARBOR, Mich., Aug. 19, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic and pharmaceutical company, today announced that [...]
Transactions under Novozymes’ stock buyback program
19/08/2019
Please read the full announcement in the attached PDF Attachment 2019_31_Stock_Buybackprogram_EN
Philips unveils HeartStart Intrepid with IntelliSpace Connect across Europe and select markets worldwide
19/08/2019
August 19, 2019 Enhanced communication and seamless data sharing capabilities augment clinical and operational efficiencies for patient assessment across emergency care settings Amsterdam, the Netherlands – Royal [...]
Aino Health AB (publ): Decreased sick leave at Botkyrka Municipality with Aino Health
19/08/2019
Aino Health implemented its SaaS solution HealthManager as a part of Botkyrka Municipality’s initiative “Focus work environment and health”, which started in September 2018. The goal of the initiative is to decrease [...]
NIH to Evaluate Iclaprim Activity against Listeria
19/08/2019
NEW YORK, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/Nasdaq: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that the Company will be utilising [...]
Vigil Reports Increased Sales Bookings in First Quarter
17/08/2019
VICTORIA, British Columbia, Aug. 16, 2019 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“Vigil”) (TSX-VEN: VGL) announces the results of operations for the quarter ending June 30, 2019. Developments in the Quarter [...]
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
16/08/2019
WALTHAM, Mass. and CRESTWOOD, Ky., Aug. 16, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Spineway : Defer of the the General Shareholders’ Meeting of August 16, 2019
16/08/2019
Defer of the the General Shareholders’ Meeting of August 16, 2019 The Ordinary and Extraordinary General Shareholders' Meeting of Spineway, convened on August 16, 2019 at 9H00 CET at the Company's registered office, has [...]
SPINEWAY : Report de l’Assemblée Générale du 16 août 2019
16/08/2019
Report de l’Assemblée Générale du 16 août 2019 L'Assemblée Générale Ordinaire et Extraordinaire des actionnaires de Spineway, convoquée le 16 août 2019 à 9H00 au siège social de la Société, n’a pas atteint le quorum [...]
Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality
16/08/2019
Expanded TAVR Indication to Younger, More Active Patients Signals Groundbreaking Shift in the Future Treatment of Heart Valve Disease DUBLIN, Aug. 16, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced U. [...]
Trading in Coloplast shares by board members, executives or associated persons
16/08/2019
NASDAQ Copenhagen 16. August 2019 Report on transactions of executives and related parties in Coloplast shares and related securities ccording to the Market Abuse Regulation article 19 Coloplast is obliged to report on [...]
Medexus Pharmaceuticals Schedules First Quarter Fiscal 2020 Conference Call
16/08/2019
Conference call to be held at 4:30 PM Eastern Time on Thursday, August 22, 2019 MONTREAL, Aug. 16, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) today [...]
CORRECTING and REPLACING - Bellicum Pharmaceuticals, Inc.
16/08/2019
Bellicum Pharmaceuticals Announces Pricing of $139.6 Million Public Offering and Private Placement Pricing of $57.5 Million Public Offering of Preferred Stock and Warrants and Entry into Concurrent Private Placement of [...]

Pages